Literature DB >> 6185581

Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). II. Qualitative characteristics of the humoral immune response to the a, d, and y determinants of HBsAg.

D R Milich, G G Leroux-Roels, F V Chisari.   

Abstract

It was previously demonstrated that the murine humoral immune responses to the common a and subtype-specific d determinants of HBsAg are H-2 restricted. The H-2q haplotype confers high responsiveness and the H-2s haplotype low responsiveness to nonresponsiveness to both determinants. We have now demonstrated that the H-2s haplotype also confers nonresponsiveness to the subtype-specific y determinant as well. Studies of H-2 congenic (nonresponder X responder)F1 and backcross mice indicated that responsiveness was inherited as a dominant trait, with no gene dosage effects observed. Qualitative characteristics of the humoral anti-a and anti-d responses were evaluated with respect to strain variation, kinetics, antigen specificity and antibody titer, affinity, and subclass distribution. Unique immune response patterns were observed for each H-2 haplotype studied. On the basis of these patterns, it was possible to construct a hierarchy of responsiveness to HBsAg of the ad subtype as follows: high responders, H-2q and H-2d; intermediate responders, H-2a greater than H-2b greater than H-2k; and nonresponders, H-2s.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  The cellular basis for lack of antibody response to hepatitis B vaccine in humans.

Authors:  E Egea; A Iglesias; M Salazar; C Morimoto; M S Kruskall; Z Awdeh; S F Schlossman; C A Alper; E J Yunis
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

2.  Non-responsiveness to hepatitis-B vaccination: revaccination and immunogenetic typing.

Authors:  A Krämer; D Herth; H J von Keyserlingk; W D Ludwig; H Hampl; D Sommer; E G Hahn; E O Riecken
Journal:  Klin Wochenschr       Date:  1988-08-01

3.  Normal HBsAg presentation and T-cell defect in the immune response of nonresponders.

Authors:  M Salazar; H Deulofeut; C Granja; R Deulofeut; D E Yunis; D Marcus-Bagley; Z Awdeh; C A Alper; E J Yunis
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Inadequate activation of the HBsAg-specific Th cells by APCs leads to hyporesponsiveness to HBsAg vaccine in B10.S mice.

Authors:  Xiaofei Li; Jing Xu; Zhihui Lv; Jing Wang; Shuhui Sun; Wei Zhu; Bin Wang; Rui He; Di Qu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection.

Authors:  P D Swenson; M R Escobar; R L Carithers; T J Sobieski
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

6.  German experimental hepatitis B vaccine--influence of variation of dosage schedule, sex and age differences on immunogenicity in health care workers.

Authors:  A Krämer; D Sommer; E G Hahn; E O Riecken
Journal:  Klin Wochenschr       Date:  1986-08-01

7.  Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.

Authors:  D R Milich; G G Leroux-Roels; R E Louie; F V Chisari
Journal:  J Exp Med       Date:  1984-01-01       Impact factor: 14.307

8.  The immune response to hepatitis B vaccine in humans: inheritance patterns in families.

Authors:  M S Kruskall; C A Alper; Z Awdeh; E J Yunis; D Marcus-Bagley
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

Review 9.  Viral Hepatitis in Indonesia: Past, Present, and Future.

Authors: 
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09

10.  Production and effect of infectious Dane particles in transgenic mice.

Authors:  K Araki; S Nishimura; T Ochiya; K Okubo; J Miyazaki; K Matsubara; K Yamamura
Journal:  Jpn J Cancer Res       Date:  1991-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.